Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
- Conditions
- Neutrophil Extracellular Traps; Antiphospholipid Antibody-induced Pregnancy Loss
- Registration Number
- NCT03735108
- Lead Sponsor
- Shanghai First Maternity and Infant Hospital
- Brief Summary
1. Establish a multi-platform detection system for neutrophil extracellular traps in blood and tissues, and evaluate the detection performance;
2. Comparing the expression levels of neutrophil extracellular traps in peripheral blood and decidua of patients with antiphospholipid antibody-induced pregnancy loss and normal control group;
3. Comparing the expression levels of neutrophil extracellular traps in peripheral blood and decidua of mice with antiphospholipid antibody-induced pregnancy loss and normal control group;
4. After treatment of antiphospholipid antibody-induced mouse abortion model with metformin,the effect of metformin on embryo loss rate and viable embryo body weight was observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
- Clinical diagnosis of Recurrent spontaneous abortion
- Clinical diagnosis of Antiphospholipid syndrome
- Other autoimmune diseases
- Hematopoietic system diseases
- Cardiovascular system diseases
- Gastrointestinal system diseases
- Urinary system diseases
- Nervous system or mental diseases
- Have taken other drugs recently
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method NETs level through study completion, an average of 8 months Neutrophil extracellular traps (NETs) are networks of extracellular fibers, primarily composed of DNA from neutrophils, which bind pathogens.
- Secondary Outcome Measures
Name Time Method complete blood count (CBC) through study completion, an average of 8 months CBC is a blood panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood, such as the cell count for each blood cell type and the concentrations of hemoglobin.
Trial Locations
- Locations (1)
Shanghai First Maternity and Infant Hospital
🇨🇳Shanghai, China